Topical Diclofenac for Prevention of Radiation-induced Dermatitis

Diclofenac Sodium Gel were applied to the skin of the irradiated site triple a day a day from the date of first radiotherapy until end of radiotherapy or until the test side skin developed ≥grade 3 RID.

The placebo does not contain the active ingredients of Jalosome, only the co-formulants.